Perivascular delivery of losartan with surgical fibrin glue prevents neointimal hyperplasia after arterial injury
Authors:
- 1 July 2004
- journal article
- research article
- Published by Elsevier in Journal of Vascular Surgery
- Vol. 40 (1) , 130-137
Abstract
No abstract availableKeywords
This publication has 19 references indexed in Scilit:
- Potential emerging therapeutic strategies to prevent restenosis in the peripheral vasculatureCatheterization and Cardiovascular Interventions, 2002
- Angiotensin II Induces Interleukin-6 Transcription in Vascular Smooth Muscle Cells Through Pleiotropic Activation of Nuclear Factor-κB Transcription FactorsCirculation Research, 1999
- The Renin-Angiotensin System and Vascular HypertrophyJACC, 1996
- Management of restenosis after coronary interventionAmerican Heart Journal, 1996
- Arterial Remodeling After Coronary AngioplastyCirculation, 1996
- Evaluation of the reproductive and developmental toxicity of the AT1‐selective angiotensin II receptor antagonist Losartan in ratsTeratology, 1995
- Migration of cultured vascular smooth muscle cells through a basement membrane barrier requires type IV collagenase activity and is inhibited by cellular differentiation.Circulation Research, 1994
- Sustained activation of vascular cells and leukocytes in the rabbit aorta after balloon injury.Circulation, 1993
- Restenosis after coronary angioplasty: An overviewJACC, 1991
- Balloon angioplasty. Natural history of the pathophysiological response to injury in a pig model.Circulation Research, 1985